Healix, LLC

Last week, Healix brought together our incredible team at the Sugar Land Town Square Plaza to mark a monumental milestone—35 years of commitment, innovation, and excellence in infusion care. The event was a heartfelt appreciation for our most valuable asset—our employees. Their unwavering dedication and passion have been at the core of our success, making Healix what it is today. From celebrating holiday cheer with a guest appearance from the Grinch to enjoying some magical, artificial snow, the evening was filled with laughter, memories, and gratitude. A special thank you to every Healix team member whose efforts have helped us achieve this remarkable legacy of infusion excellence over the years. Your dedication is not just a part of our success, but it is the very essence that continues to shape the future of care. To the healthcare community, thank you for trusting Healix to deliver quality and compassion for over three decades. We look forward to building on this tradition for many years to come. #Healix #35Years #InfusionExcellence #EmployeeAppreciation #Infusion #InfusionTherapy #SugarLand #Texas #Houston #Healthcare #Community

Happy Thanksgiving from all of us at Healix Infusion Therapy! 🧡 We’re thankful for the amazing community we’re lucky to be part of—our dedicated team, loyal clients and industry partners, and inspiring patients. May your day be full of family, friends, and everything that makes you happy. Here’s to a season of gratitude and connection. #Grateful #Thankful #Gratitude #Community #TurkeyDay

The American College of Gastroenterology 2024 Annual Scientific Meeting kicks off this weekend in Philadelphia, and the Healix Research Team is honored to be presenting 3 new collaborative poster presentations alongside our partners at GI Alliance, Capital Digestive Care, and the University of Houston College of Pharmacy.     While you're at #ACG2024, be sure to visit our studies in the poster hall and speak with presenting authors early next week:   Monday, October 28, from 1:00-2:15pm  P2570: Real-World Experience with Microbiota Treatment for the Prevention of Recurrent Clostridioides difficile Infection, presented by Timothy Ritter. P2571: Real-world Effectiveness and Onset of Action of Vedolizumab as a First-line Biologic in Biologic-Naïve Patients With Ulcerative Colitis, presented by Timothy Ritter.   Tuesday, October 29, from 1:00-2:15pm P4271: Effectiveness of A Community-based Inflammatory Bowel Disease Medical Home Compared to Patients not in a Medical Home, presented by Erica R. Cohen, MD.   Want to learn more about Healix research? Reach out to Lucinda Van Anglen, PharmD, FIDSA.     #clinicalresearch #gastroenterology

Happy National Pharmacy Week 2024! This week, we honor our incredible Pharmacy Team at Healix. Every day, our talented pharmacists and pharmacy technicians bring dedication and professionalism to their essential roles. Their unwavering commitment to delivering top-notch medications and services makes a profound impact on the lives of our patients. This year's theme, "We are PHARMACY," truly reflects the passion and excellence our team brings to the healthcare industry. We're deeply grateful for your hard work and dedication—thank you for everything you do to provide Patient and Physician Peace of Mind! 🙌 #PharmacyWeek #WeArePharmacy #Celebrate #Grateful #Healthcare #Healix #HealixInfusion

The stars have arrived in L.A. for #IDWeek 2024! Swing by the Healix booth 241 to chat with Mark Elvanian, Casey Lucas, and Nick Tycom. You never know -- you may also run into Marilyn while you're there. #IDWeek2024 #IDSA #OnlyinLA

The Healix Research Team is honored to showcase a new poster presentation alongside our physician partners Richard Herrscher and Jeff Langford and Octapharma at the Immunoglobulin National Society (IgNS) 2024 13th National Conference this weekend.  If you'll be at the conference, be sure to visit with presenting author Lucinda Van Anglen, PharmD, FIDSA during the Poster Session this Saturday, 10/19, from 4:30-6:00pm in the Maryland Ballroom Foyer.    Poster 105: Immune Globulin Subcutaneous 16.5% in Treatment of Primary Immunodeficiency: A Two-Year, Multi-Center Analysis   Congratulations to the entire collaborative research team and all those participating at IgNS!    #IgNS #immunodeficiency #clinicalresearch 

The Healix Research Team is excited to be presenting four new collaborative studies at #IDWeek2024 with our physician partners. While attending the premier meeting of infectious disease professionals, be sure to stop by our studies and chat with presenting authors.    Study P-570: Infectious Disease Physician Office-Based HIV Program Results in Successful Adherence of Therapy in Patients Receiving Long-Acting Cabotegravir and Rilpivirine. Presented by Nikhil Bhayani, MD,FIDSA on 10/17/24 at 12:15pm-1:30pm PT in Hall J & K   Study P-220: Real-World Effectiveness of Fecal Microbiota, live-jslm for the Prevention of Recurrent Clostridioides difficile Infection. Presented by Rick Hengel on 10/17/24 at 12:15pm-1:30pm PT in Hall J & K   Study P-1240: Optimal Vancomycin Model Selection for Obese Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT). Presented by Kimberly Couch on 10/18/24 at 12:15pm-1:30pm PT in Hall J & K    Study P-1873: Telavancin Outcomes in Infections Treated with Outpatient Parenteral Antibiotic Therapy (OPAT). Presented by Brian Metzger on 10/19/24 at 12:15pm-1:30pm PT in Hall J & K   Congratulations to our entire research team! We hope to see you at #IDWeek 2024. If you're interested in learning more about our research studies or partnering with Healix, contact Lucinda Van Anglen, PharmD, FIDSA.    #clinicalresearch #IDWeek #IDSA #infectiousdiseases

It's not too late to register to attend #IDWeek2024! If you're an infectious diseases health professional, you won't want to miss the premier meeting starting October 16 in Los Angeles.     Once you're there, don't forget to swing by booth #241 in the Exhibit Hall to chat with the Healix Team to learn how our infusion management solutions and clinical research support the ID community. We are dedicated to promoting the highest quality of patient infusion care while enhancing our client's practices through a physician office-based program. If you'd like to schedule a one-on-one chat, feel free to reach out to Mark Elvanian.    Ready to learn more about IDWeek or register to attend? Visit www.idweek.org.     See you at IDWeek!    #IDWeek #infectiousdiseases #IDSA

We're thrilled to recognize Blake Griese for his recent feature in The Purdue Pharmacist by the Purdue University College of Pharmacy! In an article titled "From Pills to Policies," Blake's incredible dual career as a pharmacist and healthcare lawyer is showcased.   From dispensing medications to shaping healthcare policies, Blake's uncommon path proves that the sky's the limit in pharmacy and law. Today, he excels as Senior Vice President of Pharmacy and General Counsel at Healix, LLC, where his deep expertise ensures that our patients and clients receive top-notch infusion and pharmacy services.   Want to be inspired? Read more about Blake’s story here > https://lnkd.in/gubBsbe2   #Pharmacists #HealthcareLaw #PurdueSchoolofPharmacy #PurdueUniversity #PurdueAlumni #Pharmacy 

We are just one month away from #IDWeek2024 in sunny LA! The meeting kicks off on October 16, and our team can't wait to see you there. Be sure to visit us at booth 241 to gain valuable insights into how premier infusion management services support ID practices and patients, allowing the physician to maintain direct supervision throughout the duration of infusion therapy.     With 35 years of experience and significant expertise in ID, we are passionate about the highest level of patient care. Schedule a time to meet with us today by emailing infusiontherapy@healix.net. We hope to see you at IDWeek! #infusiontherapy #IDSA #IDWeek #IDWeek2024 #infectiousdiseases